Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPT2 | P23786 | 1/20 | 0.43 |
| ▸ | ACLY | P53396 | 1/20 | 0.43 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7199435 | 0.86 | ACLY (0.50) | CPT2ACLYHSPD1BLMHSPE1 | |
| SCHEMBL1538353 | 0.79 | CPT2 (0.40) | CPT2ACLYHSPD1BLMHSPE1 | |
| SCHEMBL3800160 | 0.76 | HSPD1 (0.39) | CPT2ACLYHSPD1BLMHSPE1 | |
| SCHEMBL27479007 | 0.75 | HSPD1 (0.58) | CPT2ACLYHSPD1BLMHSPE1 | |
| SCHEMBL7590952 | 0.75 | HTT (0.35) | GRIK1GRIK2 | |
| SCHEMBL27464800 | 0.72 | ACLY (0.50) | CPT2ACLYHSPD1BLMHSPE1 | |
| SCHEMBL5610786 | 0.70 | HSPD1 (0.79) | HSPD1BLMHSPE1 | |
| SCHEMBL5473948 | 0.70 | ACLY (0.69) | CPT2ACLYHSPD1BLMHSPE1 | |
| SCHEMBL6455497 | 0.70 | GRIK1 (0.34) | ALDH1A1GRIK1GRIK2 | |
| SCHEMBL2557188 | 0.68 | HSPD1 (0.64) | CPT2ACLYHSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6849576-B2 | Plant-activating agent | KAO CORPORATION (JP) | 2005-02-01 | — | — | US | disclosed |
| US-20020006872-A1 | Plant-activating agent | KAO CORPORATION (JP) | 2002-01-17 | — | — | US | disclosed |
| EP-1151668-A2 | Plant-activating agent | KAO CORPORATION (JP) | 2001-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020006872-A1 | Plant-activating agent | ALPG, ARFGEF1, PMAIP1 | CPT2 4231/4885ACLY 3097/4885HSPD1 951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.